Table 4.
Exposure⋆ | Cases (n = 13) | Controls (n = 77) | Odds ratio | 95% CI |
---|---|---|---|---|
Nonexposed⋆⋆ | 4 | 15 | 1.0 | Reference |
CCBs | 1 | 12 | 0.3 | 0.02, 3.3 |
β-adrenoceptor blockers | 3 | 25 | 0.5 | 0.1, 2.5 |
ACE inhibitors | 2 | 9 | 0.7 | 0.1, 5.6 |
Other | 2 | 6 | 1.2 | 0.1, 11.8 |
Multiple study drugs with CCBs | 1 | 6 | 0.7 | 0.1, 7.2 |
Multiple study drugs without CCBs | 0 | 4 | – | – |
Exposure categories are mutually exclusive.
Reference group.